CIK: 0001535610
Total reported value
$45.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABBV | AbbVie Inc. | Stock-Healthcare | 11.93% | — | -5.33% | |
| 2 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 7.88% | — | — | |
| 3 | ✓ | Alnylam Pharmaceuticals INC | Stock-Other | 6.92% | — | +173.05% | |
| 4 | ✓ | Bluebird Bio INC | Stock-Other | 6.79% | — | +57.87% | |
| 5 | ✓ | Dbv Technologies S A | Stock-Other | 5.82% | — | — | |
| 6 | VRTX | Vertex Pharmaceuticals Incorporated | Stock-Healthcare | 5.48% | — | -37.07% | |
| 7 | ✓ | Alnylam Pharmaceuticals INC | Stock-Other | 4.68% | — | +32.37% | |
| 8 | SRPT | Sarepta Therapeutics, Inc. | Stock-Healthcare | 4.14% | — | +28.64% | |
| 9 | MRK | Merck & Co., Inc. | Stock-Healthcare | 3.37% | — | -40.56% | |
| 10 | ✓ | Halozyme Therapeutics INC | Stock-Other | 2.85% | — | +89.85% | |
| 11 | VRTX | Vertex Pharmaceuticals Incorporated | Stock-Healthcare | 2.40% | — | +54.99% | |
| 12 | ✓ | Zogenix INC | Stock-Other | 2.14% | — | +180.40% | |
| 13 | AZN | AstraZeneca PLC | Stock-Healthcare | 1.91% | — | -81.62% | |
| 14 | CI | The Cigna Group | Stock-Healthcare | 1.58% | — | -73.50% | |
| 15 | ✓ | Gw Pharmaceuticals PLC | Stock-Other | 1.47% | — | +148.16% | |
| 16 | ✓ | Kite Pharma INC | Stock-Other | 1.23% | — | -31.35% | |
| 17 | ✓ | Seattle Genetics INC. | Stock-Other | 1.19% | — | +20.25% | |
| 18 | ✓ | Clovis Oncology INC | Stock-Other | 1.15% | — | -60.83% | |
| 19 | ✓ | Ionis Pharmaceuticals INC | Stock-Other | 1.03% | — | +28.04% | |
| 20 | ✓ | Bluebird Bio INC | Stock-Other | 0.98% | — | +19.45% | |
| 21 | ✓ | Dbv Technologies S A | Stock-Other | 0.95% | — | — | |
| 22 | ✓ | Fibrogen INC | Stock-Other | 0.94% | — | -9.95% | |
| 23 | ✓ | Esperion Therapeutics INC Ne | Stock-Other | 0.93% | — | +475.49% | |
| 24 | ✓ | Ionis Pharmaceuticals INC | Stock-Other | 0.91% | — | +10.05% | |
| 25 | AZN | AstraZeneca PLC | Stock-Healthcare | 0.87% | — | -46.60% | |
| 26 | ✓ | Prothena CORP PLC | Stock-Other | 0.81% | — | +17.12% | |
| 27 | ✓ | United Therapeutics CORP Del | Stock-Other | 0.80% | — | -60.23% | |
| 28 | ✓ | Amicus Therapeutics INC | Stock-Other | 0.78% | — | -16.54% | |
| 29 | ✓ | Sangamo Therapeutics INC | Stock-Other | 0.75% | — | +2.36% | |
| 30 | ✓ | Insmed INC | Stock-Other | 0.73% | — | -2.53% | |
| 31 | ✓ | Amag Pharmaceuticals INC Cmn Stk | Stock-Other | 0.70% | — | +40.37% | |
| 32 | ✓ | Axovant Sciences LTD | Stock-Other | 0.66% | — | +106.09% | |
| 33 | ✓ | Cytokinetics INC | Stock-Other | 0.62% | — | +8.15% | |
| 34 | ✓ | Zogenix INC | Stock-Other | 0.56% | — | -66.67% | |
| 35 | ✓ | Amarin Corp PLC | Stock-Other | 0.56% | — | -10.71% | |
| 36 | ✓ | Axovant Sciences LTD | Stock-Other | 0.56% | — | — | |
| 37 | ✓ | Sage Therapeutics INC | Stock-Other | 0.55% | — | +65.57% | |
| 38 | ✓ | Insmed INC | Stock-Other | 0.54% | — | +96.15% | |
| 39 | ESPR | Esperion Therapeutics INC | Stock-Other | 0.53% | — | — | |
| 40 | ✓ | Oncobiologics INC | Stock-Other | 0.41% | — | +0.77% | |
| 41 | ✓ | Five Prime Therapeutics INC | Stock-Other | 0.39% | — | — | |
| 42 | ✓ | Seattle Genetics INC. | Stock-Other | 0.37% | — | +23.74% | |
| 43 | GWPH | Gw Pharmaceuticals LTD | Stock-Other | 0.36% | — | +81.48% | |
| 44 | MRK | Merck & Co., Inc. | Stock-Healthcare | 0.36% | — | +8.03% | |
| 45 | ✓ | Ptc Therapeutics INC | Stock-Other | 0.32% | — | +30.71% | |
| 46 | ✓ | Sarepta Therapeutics INC | Stock-Other | 0.30% | — | +684.85% | |
| 47 | SGENEUR | Seagen INC | Stock-Other | 0.29% | — | -49.92% | |
| 48 | ✓ | Incyte CORP | Stock-Other | 0.27% | — | +84.00% | |
| 49 | ✓ | Check Cap LTD | Stock-Other | 0.27% | — | -16.49% | |
| 50 | BMY | Bristol-Myers Squibb Company | Stock-Healthcare | 0.27% | — | -0.68% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Spdr S&p 500 ETF Tr | +3% | +51.47% | Add |
| 2 | ✓ | Alnylam Pharmaceuticals INC | +2.7% | +173.05% | Add |
| 3 | ✓ | Ishares Tr | +2.1% | +47.36% | Add |
| 4 | ✓ | Bluebird Bio INC | +1.8% | +57.87% | Add |
| 5 | BMY | Bristol-Myers Squibb Company | +1.6% | -0.68% | Trim |
| 6 | MRK | Merck & Co., Inc. | +1.3% | +8.03% | Add |
| 7 | ✓ | Alnylam Pharmaceuticals INC | +1.2% | +32.37% | Add |
| 8 | ✓ | Zogenix INC | +1% | +180.40% | Add |
| 9 | SRPT | Sarepta Therapeutics, Inc. | +0.9% | +28.64% | Add |
| 10 | ✓ | Halozyme Therapeutics INC | +0.9% | +89.85% | Add |
| 11 | ABBV | AbbVie Inc. | +0.9% | -5.33% | Trim |
| 12 | VRTX | Vertex Pharmaceuticals Incorporated | +0.6% | +54.99% | Add |
| 13 | ✓ | Gw Pharmaceuticals PLC | +0.5% | +148.16% | Add |
| 14 | ✓ | Esperion Therapeutics INC Ne | +0.4% | +475.49% | Add |
| 15 | ✓ | Insmed INC | +0.2% | +96.15% | Add |
| 16 | ✓ | Bluebird Bio INC | +0.2% | +19.45% | Add |
| 17 | ✓ | Sangamo Therapeutics INC | +0.2% | +2.36% | Add |
| 18 | ✓ | Insmed INC | +0.2% | -2.53% | Trim |
| 19 | ✓ | Axovant Sciences LTD | -0.2% | +106.09% | Add |
| 20 | AZN | AstraZeneca PLC | -0.4% | -46.60% | Trim |
| 21 | T8S | Tesaro INC | -0.4% | -93.19% | Trim |
| 22 | ✓ | Axovant Sciences LTD | -0.7% | -73.61% | Trim |
| 23 | ✓ | United Therapeutics CORP Del | -0.7% | -60.23% | Trim |
| 24 | ✓ | Tesaro INC | -0.8% | -88.67% | Trim |
| 25 | VRTX | Vertex Pharmaceuticals Incorporated | -1% | -37.07% | Trim |
| 26 | ✓ | Clovis Oncology INC | -1.1% | -60.83% | Trim |
| 27 | MRK | Merck & Co., Inc. | -1.2% | -40.56% | Trim |
| 28 | CI | The Cigna Group | -2% | -73.50% | Trim |
| 29 | AZN | AstraZeneca PLC | -4.5% | -81.62% | Trim |
| 30 | BMY | Bristol-Myers Squibb Company | -7.3% | -99.79% | Trim |
| 31 | BMY | Bristol-myers Squibb Co | — | NEW | New buy |
| 32 | ✓ | Dbv Technologies S A | — | NEW | New buy |
| 33 | ✓ | United Therapeutics CORP Del | — | EXIT | Sold out |
| 34 | ✓ | Dynavax Technologies CORP | — | EXIT | Sold out |
| 35 | ✓ | Alexion Pharmaceuticals INC | — | EXIT | Sold out |
| 36 | ✓ | Cerner CORP | — | EXIT | Sold out |
| 37 | ✓ | Dbv Technologies S A | — | NEW | New buy |
| 38 | UTHR | United Therapeutics CORP | — | EXIT | Sold out |
| 39 | ✓ | Alexion Pharmaceuticals INC | — | EXIT | Sold out |
| 40 | ✓ | Select Sector Spdr Tr | — | EXIT | Sold out |
| 41 | ✓ | Spectranetics CORP Cmn Stk | — | EXIT | Sold out |
| 42 | ✓ | Axovant Sciences LTD | — | NEW | New buy |
| 43 | ESPR | Esperion Therapeutics INC | — | NEW | New buy |
| 44 | ✓ | Spectranetics CORP | — | EXIT | Sold out |
| 45 | ✓ | Spdr Series Trust | — | EXIT | Sold out |
| 46 | KRG | Kite Realty Group Trust | — | EXIT | Sold out |
| 47 | ✓ | Pacira Biosciences INC | — | EXIT | Sold out |
| 48 | ✓ | Pacira Biosciences INC | — | EXIT | Sold out |
| 49 | ✓ | Five Prime Therapeutics INC | — | NEW | New buy |
| 50 | ✓ | Biolinerx Ltd-spons Adr | — | EXIT | Sold out |